|
Bio-Rad
rat anti mouse monoclonal f4 80 Rat Anti Mouse Monoclonal F4 80, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/f4/Rat+anti+Mouse+F4%2F80/10__22203_slash_ecm__v033a11-129-8-16 Average 96 stars, based on 1 article reviews
rat anti mouse monoclonal f4 80 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
anti f4 80 Anti F4 80, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/f4/F4%2F80+XP+Rabbit+mAb/pmc13770902-39-29-30 Average 98 stars, based on 1 article reviews
anti f4 80 - by Bioz Stars,
2026-11
98/100 stars
|
Buy from Supplier |
|
Proteintech
f4 80 F4 80, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/f4/F4%2F80+Antibody/pm42875944-344-6-7 Average 96 stars, based on 1 article reviews
f4 80 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
f4 80 ![]() F4 80, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/f4/F4%2F80+Antibody/pmc13748629-100-40-43 Average 97 stars, based on 1 article reviews
f4 80 - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
Proteintech
anti f4 80 ![]() Anti F4 80, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/f4/F4%2F80+Antibody/pm43004435-113-16-17 Average 96 stars, based on 1 article reviews
anti f4 80 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Proteintech
tongue sections ![]() Tongue Sections, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/f4/F4%2F80+Antibody/pm43002206-201-3-12 Average 96 stars, based on 1 article reviews
tongue sections - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Proteintech
fitc conjugated anti f4 80 antibody ![]() Fitc Conjugated Anti F4 80 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/f4/F4%2F80+Antibody/pm42985724-416-15-20 Average 96 stars, based on 1 article reviews
fitc conjugated anti f4 80 antibody - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
f4 80 ![]() F4 80, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/f4/F4%2F80+XP+Rabbit+mAb/pm42988024-103-19-21 Average 98 stars, based on 1 article reviews
f4 80 - by Bioz Stars,
2026-11
98/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
10058 f4 ![]() 10058 F4, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/f4/10058-F4/pm42980512-49-61-62 Average 95 stars, based on 1 article reviews
10058 f4 - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
Journal: Cancer Communications
Article Title: Combined Immunotherapy and Hybrid Dose-Fraction Radiotherapy for Driver-Negative Metastatic NSCLC: A Phase II Trial with Parallel Preclinical Studies
doi: 10.34133/cancomm.0065
Figure Lengend Snippet: Myeloid–fibroblast interaction and Spp1 + macrophage analysis in metastatic lesions. (A) UMAP plot of myeloid-subtype cells from scRNA-seq data of lung tissues from the Control, anti-PD-1, ISABR, and IHBRT groups ( n = 3/group), colored by cell type. (B) Average expression and percentage of cells expressing representative marker genes across the indicated myeloid-subtype cells. (C) Bar plot showing the relative proportion of cells from 4 treatment groups for myeloid subtypes ( n = 3/group). (D) Information flow showing signaling pathways ranked based on differences between ISABR and IHBRT. (E) Communication of the SPP1 signaling pathway network between myeloid subtypes and fibroblast cells. (F) Volcano plot showing differentially expressed genes of macrophages between IHBRT and ISABR. Red: significantly up-regulated genes, P < 0.05 and log 2 (fold change) > 0.25. Blue: significantly down-regulated genes, P < 0.05 and log 2 (fold change) < −0.25. Gray: ns. (G) Kaplan–Meier curves of OS in TCGA-LUAD and TCGA-LUSC cohorts. Patients were dichotomized by the SPP1 + macrophage signature score at the data-driven optimal cutoff (high score, n = 334; low score, n = 670). (H) Representative flow cytometry plots (left) and the proportion (right) of Spp1 + in CD11b + F4/80 + cells in lung tissue ( n ≥ 3/group). (I) Representative mIF images in lung tissue on day 21. Differential expression analysis was performed using the Wilcoxon rank-sum test with Benjamini–Hochberg correction. Survival curves were compared using the log-rank test; HRs were estimated using a Cox proportional hazards model. Error bars indicate mean ± SD. ns, not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: ANOVA, analysis of variance; anti-PD-1, anti-programmed cell death protein 1 antibody; CD11b, cluster of differentiation 11b; DC, dendritic cell; IHBRT, ICI plus Hybrid-RT; ISABR, ICI plus SABR; KEGG, Kyoto Encyclopedia of Genes and Genomes; mIF, multiplex immunofluorescence; OS, overall survival; scRNA-seq, single-cell RNA sequencing; SD, standard deviation; SPP1, secreted phosphoprotein 1; TCGA-LUAD, The Cancer Genome Atlas-lung adenocarcinoma; TCGA-LUSC, The Cancer Genome Atlas-lung squamous cell carcinoma; UMAP, uniform manifold approximation and projection; ns, not significant.
Article Snippet: Sections were incubated overnight at 4 °C with primary antibodies against CD8 (Cat. #ab217344, Abcam), CD3 (Cat. #ab135372, Abcam), NK1.1 (Cat. #ab289542, Abcam), CXCR3 (Cat. #ab288437, Abcam), C-X-C motif chemokine ligand 10 (CXCL10, Cat. #10937-1-AP, Proteintech), GZMB (Cat. #13588-1-AP, Proteintech),
Techniques: Analysis, Control, Expressing, Marker, Protein-Protein interactions, Flow Cytometry, Tissue, Quantitative Proteomics, Multiplex Assay, Immunofluorescence, Single Cell, RNA Sequencing, Standard Deviation